Cargando…

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children

Detalles Bibliográficos
Autores principales:	Stockmann, Chris, Sherwin, Catherine M. T., Knackstedt, Elizabeth D., Hersh, Adam L., Pavia, Andrew T., Spigarelli, Michael G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289335/ https://www.ncbi.nlm.nih.gov/pubmed/26962197 http://dx.doi.org/10.1093/jpids/piw008

Ejemplares similares

Effect of ganciclovir for the treatment of severe cytomegalovirus-associated pneumonia in children without a specific immunocompromised state
por: Doan, Thanh Thi Mai, et al.
Publicado: (2013)

Ganciclovir therapeutic drug monitoring in transplant recipients
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Ganciclovir: Where Are We?
por: Märtson, Anne-Grete, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Ganciclovir in Cytomegalovirus-Infected Patients With Solid Organ Transplants and Its Correlation to Efficacy and Toxicity
por: van der Wekken-Pas, Lena C., et al.
Publicado: (2023)

Ganciclovir Therapeutic Drug Monitoring: A Case Series
por: Märtson, Anne-Grete, et al.
Publicado: (2019)

Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report
por: Sunada, Mariko, et al.
Publicado: (2016)

1538. Who Will Benefit From Therapeutic Drug Monitoring of Ganciclovir?
por: Martson, Anne-Grete, et al.
Publicado: (2019)

Ganciclovir/letermovir: Rebound Cytomegalovirus hepatitis, acquired resistance to ganciclovir and nephrotoxicity: case report
Publicado: (2020)

Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates
por: Stockmann, Chris, et al.
Publicado: (2015)

Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry
por: Stockmann, Chris, et al.
Publicado: (2013)

Cytomegalovirus pneumonitis in an immunocompromised host
por: Balakrishnan, Rabitha, et al.
Publicado: (2022)

Ganciclovir-resistant cytomegalovirus infection in renal transplantation
por: Vaz, Raquel, et al.
Publicado: (2014)

Presumed neonatal cytomegalovirus retinitis treated with intravenous ganciclovir
por: Suganya, A, et al.
Publicado: (2020)

Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation
por: Papazian, Laurent, et al.
Publicado: (2021)

Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship
por: Galar, Alicia, et al.
Publicado: (2021)

Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis
por: Choopong, Pitipol, et al.
Publicado: (2016)

Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection
por: Natale, Fabio, et al.
Publicado: (2015)

Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
por: Khurana, Mark P, et al.
Publicado: (2019)

Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis
por: Wong, John X. H., et al.
Publicado: (2016)

Helicobacter pylori and Immunocompromised Children
por: Nutpho, Prakaimuk, et al.
Publicado: (2006)

Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir
por: Ahmed, Iftikhar, et al.
Publicado: (2018)

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

The need for area under the curve measurements in the field of ganciclovir therapeutic drug monitoring in children: a case report
por: Duval, Xavier, et al.
Publicado: (2021)

Fecal Microbiota Transplantation (FMT) for Recurrent/Refractory Clostridium difficile Infection (CDI) in Pediatric Immunocompromised Patients: A Single-center Experience
por: Kwendakwema, Natasha, et al.
Publicado: (2017)

Non-healing Vulval Ulcer in an Immunocompromised Female due to Concurrent Herpes Simplex Virus and Cytomegalovirus Co-infection Treated Effectively with Valganciclovir
por: Sinha, Preema, et al.
Publicado: (2020)

The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein
por: Shannon-Lowe, Claire D, et al.
Publicado: (2010)

Successful Treatment with Ganciclovir for Cytomegalovirus Duodenitis following Allogenic Bone Marrow Transplantation
por: Ahn, Jin Hee, et al.
Publicado: (1999)

Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
por: Jang, Hyo-Jeong, et al.
Publicado: (2012)

Predictor of Liver Biochemistry Improvement in Patients with Cytomegalovirus Cholestasis after Ganciclovir Treatment
por: Puspita, Gina, et al.
Publicado: (2022)

Acute invasive fungal sinusitis in immunocompromised children
por: Kebudi, Rejin
Publicado: (2022)

Testing for Cytomegalovirus Among Individuals Who Were Immunocompromised, 2018-2022
por: Jain, Purva, et al.
Publicado: (2023)

Cytomegalovirus Esophagitis in an Immunocompromised Patient
por: Ali, Adya A, et al.
Publicado: (2023)

A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots
por: Pigliasco, Federica, et al.
Publicado: (2021)

Cytomegalovirus Retinitis in an ALL Child during Maintenance Therapy Treated Successfully with Intravenous Ganciclovir
por: Celiker, Hande, et al.
Publicado: (2014)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
por: Vaziri, Siavash, et al.
Publicado: (2014)

Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation
por: Andrassy, Joachim, et al.
Publicado: (2009)

Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir
por: Saraca, Lavinia Maria, et al.
Publicado: (2018)

Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients
por: Qian, Zhuyun, et al.
Publicado: (2018)

Cytomegalovirus Myocarditis Required Extracorporeal Membrane Oxygenation Support Followed by Ganciclovir Treatment in Infant
por: Kim, Bong Jun, et al.
Publicado: (2016)

Effectiveness of Topical Ganciclovir 2% Monotherapy Versus Combined Steroid Therapy in Cytomegalovirus Endotheliitis
por: Kuo, Yu-Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nifim9guqaa9rklaktpp2f9clb